The best indicator for Albemarle Corporation (ALB)
We backtested 20 indicators across daily, weekly and hourly charts on real Albemarle Corporation (ALB) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Bollinger Mean-Reversion
On the weekly chart, this is the strongest risk-adjusted edge we found for Albemarle Corporation (ALB) over ~32.4 years — trailing buy-and-hold by 4.1% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Bollinger Mean-Reversion ✓ | Weekly | 8.1% | 0.49 | -36.8% | 80.0% | 30 | -4.1% |
| 2 | Donchian Breakout ✓ | Weekly | 8.7% | 0.47 | -48.5% | 47.8% | 23 | -3.4% |
| 3 | EMA 50/200 Cross ✓ | Daily | 9.4% | 0.46 | -52.6% | 50.0% | 22 | -2.4% |
| 4 | SMA 50/200 Cross ✓ | Daily | 9.0% | 0.45 | -58.9% | 46.2% | 26 | -2.8% |
| 5 | WaveTrend (8/6/4) ✓ | Weekly | 6.7% | 0.38 | -72.3% | 78.3% | 23 | -5.5% |
| 6 | Heikin-Ashi Trend ✓ | Weekly | 6.4% | 0.37 | -66.3% | 47.6% | 292 | -5.7% |
| 7 | Donchian Midline ✓ | Weekly | 6.5% | 0.37 | -68.5% | 38.1% | 97 | -5.7% |
| 8 | Holy Grail Confluence ✓ | Daily | 5.8% | 0.36 | -58.9% | 72.5% | 51 | -6.0% |
| 9 | EMA 20/50 Cross ✓ | Daily | 6.2% | 0.35 | -68.9% | 37.4% | 91 | -5.7% |
| 10 | EMA 20/50 Cross ✓ | Weekly | 6.7% | 0.37 | -61.4% | 42.9% | 14 | -5.5% |
| 11 | MACD ✓ | Weekly | 5.3% | 0.33 | -74.6% | 43.5% | 62 | -6.8% |
| 12 | Rate of Change ✓ | Weekly | 5.1% | 0.32 | -63.7% | 48.3% | 116 | -7.1% |
| 13 | RSI Mean-Reversion ✓ | Daily | 4.1% | 0.3 | -54.5% | 75.0% | 48 | -7.7% |
| 14 | Money Flow Index ✓ | Daily | 4.6% | 0.3 | -65.2% | 62.9% | 35 | -7.2% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Albemarle Corporation (ALB), Bollinger Mean-Reversion on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.